Lexicon Pharma (LXRX) Update on Symphony Icon Obligation; Received $23M Upfront from Ipsen Pharma
Tweet Send to a Friend
Lexicon Pharm (Nasdaq: LXRX) disclosed the following on Friday morning:On December 4, 2014, we issued 4,662,780 shares (the “Shares”) of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
